1. ‣Thomas Adams, Ph.D.                  
   

    Chairman of the Board

1. ‣Corporate VP and CTO, IRIS International, Inc. (2006 to Present)
   

2. ‣Founder and CEO, Leucadia Technologies (1998-2006)
   

3. ‣Co-founder and CEO of Genta, Inc. (1989-1997)
   

4. ‣Co-Founder/Chairman/CEO, Gen-Probe, Inc.(1984-1989)
   

5. ‣Member of founding team, Sr. VP of R&D, and CTO, Hybritech, Inc. (1980-1984)
   

1. ‣Antonius Schuh, Ph.D.          
   

    Chief Executive Officer

1. ‣Antonius Schuh, Ph.D. was appointed Chief Executive Officer of Trovagene, Inc. on October 4, 2011.
   

2. ‣He previously served as Chairman and Chief Executive Officer of Sorrento Therapeutics, Inc. (SRNE.PK), a  biotechnology company he co-founded based on a proprietary platform to generate very large fully human mAb libraries.
   

3. ‣Previously, he was the founding CEO of AviaraDx, Inc., a leading molecular diagnostic innovator in oncology. In 2008, Dr. Schuh led the sale of AviaraDx to bioMerieux, which continues to operate AviaraDx under the name bioTheranostics. Before AviaraDx, Dr. Schuh served as CEO of Arcturus Bioscience, Inc., where he led the sale of Arcturus’ life science business to Molecular Devices, Inc., now part of Life Technologies.
   

4. ‣Prior to Arcturus, Dr. Schuh served as the President and Chief Executive Officer of Sequenom, Inc. He joined Sequenom as Managing Director of the company’s German operations, Sequenom GmbH, from Helm AG of Hamburg, an international trading and distribution corporation for chemical and pharmaceutical products. At Helm, he headed the Business Development Group of the Pharmaceutical Division and the associated Technical and Regulatory Affairs department.
   

5. ‣Prior to Helm, Dr. Schuh was with Fisons Pharmaceuticals (now part of Sanofi Aventis), where he held medical and regulatory affairs positions and served as member of the management teams of Fisons AG, Switzerland, and Fisons Ges.m.b.H, Austria. Dr. Schuh holds a degree in pharmaceutics and earned his Ph.D. in medicinal chemistry from the University of Bonn, Germany.
   

6. ‣He currently serves as a Director of Diogenix, Inc. and Transgenomic, Inc. (TBIO.OB).
   

1. ‣David Robbins, Ph.D.
   

    VP, Research & Development

1. ‣Vice President R&D, Xenomics, Inc. (2009-Present)
   

2. ‣VP of Product Development, Xenomics, Inc. (2006-2009)
   

3. ‣VP of R&D, ChromoLogic, LLC (2004-2006)
   

4. ‣Director, Microarray Applications, ViaLogy (2001-2004)
   

5. ‣Various Research & Development positions at Quest Diagnostics, SmithKline Beecham, and Abbott Diagnostics

» About Us

» Our Mission

» Business Strategy

» Management

» Board of Directors

TROV.PK

TrovaGene Inc., 11055 Flintkote Ave., Suite B, San Diego, CA 92121

TROVAGENE INC (TROV.PK)